Analysis of clinical data revealed that CSE1L was overexpressed in osteosarcoma tissues compared to non-tumor tissues and that increased CSE1L expression in osteosarcoma was associated with a higher recurrence rate and poor survival. The gene discussed is CSE1L; the disease is neoplasm.